DFO
LLY icon

Duquesne Family Office’s Eli Lilly LLY Stock Holding History

Duquesne Family Office’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100,675
Closed -$78.5M – 90
2025
Q2 		$78.5M Buy
100,675
+5,845
+6% +$4.54M 1.93% 16
2025
Q1 		$78.3M Buy
94,830
+32,640
+52% +$27.2M 2.56% 12
2024
Q4 		$48M Buy
+62,190
New +$51.5M 1.29% 20
2024
Q2 		– Sell
-61,664
Closed -$48M – 77
2024
Q1 		$48M Sell
61,664
-340,886
-85% -$243M 1.09% 23
2023
Q4 		$235M Sell
402,550
-51,565
-11% -$30.1M 7% 5
2023
Q3 		$244M Sell
454,115
-82,330
-15% -$42.4M 8.75% 4
2023
Q2 		$252M Sell
536,445
-69,765
-12% -$29.3M 8.75% 4
2023
Q1 		$208M Sell
606,210
-131,515
-18% -$44.4M 9.02% 4
2022
Q4 		$270M Buy
737,725
+252,830
+52% +$89.6M 13.36% 2
2022
Q3 		$157M Buy
484,895
+187,745
+63% +$59.5M 8.89% 2
2022
Q2 		$96.3M Buy
+297,150
New +$89.2M 6.97% 4

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Duquesne Family Office's LLY Position: Q3 2025 in Review

Duquesne Family Office sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 100,675 shares — an estimated $78.5M sold.

Duquesne Family Office first reported a position in LLY in Q2 2022 and held it in 11 quarters. The position peaked at $270M in Q4 2022. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Duquesne Family Office reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Duquesne Family Office sold 100,675 Eli Lilly shares in Q3 2025, an estimated $78.5M.
  • Duquesne Family Office first reported a position in Eli Lilly in Q2 2022 and held it in 11 quarters.
  • Duquesne Family Office's Eli Lilly position peaked at $270M in Q4 2022.
  • 3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Duquesne Family Office's 13F filing for Q3 2025, filed 14 Nov 2025.